Xun Xu
Xu Xun, PhD, Director of BGI-Research, Executive director of BGI Group, Doctoral supervisor of University of Chinese Academy of Sciences. Dr. Xu is appointed as WG convenor of International Organization for Standardization/Biotechnology Committee (ISO/TC276), and on the National Committee for Standardization of Biological Specimens. In addition, he is also elected as Director-at-Large–China of International Society for Biological and Environmental Repositories (ISBER).
His research focuses on the sequencing technologies, single-cell sequencing, stereo-seq technologies and applications of sequencing technologies in precision medicine and biodiversity. Dr. Xu has authored or co-authored 300+ scientific papers published in top international peer-reviewed journals including Nature, Science, and Cell. The number of citations using his published papers in the past five years has reached more than 50,000 times. He’s also Selected as a "Highly Cited Scientist" by Clarivate Analytics for eight consecutive years.
Dr. Xu has either led or participated in several major national scientific research projects and several international projects, including the National 863 Sequencer Project, the National Key R&D Program, and the National Development and Reform Commission's Industrial Agglomeration Project. He has been awards with many honors, such as “Grand Challenges-Young Scientist” by MOST and Bill & Melinda Gates Foundation, “Guangdong Science and Technology Award”, “Natural Science Award of MOE”.
Abstracts this author is presenting: